MétaCan
Menu
Back to cohort
Record W1855129715 · doi:10.13034/jsst.v8i2.63

Using Aptamer-Nanoparticle Bioconjugates For Imaging and Treating Prostate Cancer

2015· article· en· W1855129715 on OpenAlexvenueno aff
Timothy James Doyle

Bibliographic record

VenueJournal of Student Science and Technology · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicAdvanced biosensing and bioanalysis techniques
Canadian institutionsnot available
Fundersnot available
KeywordsAptamerBioconjugationProstate cancerCancer researchChemistryMedicineCancerMolecular biologyBiologyInternal medicineCombinatorial chemistry

Abstract

fetched live from OpenAlex

Prostate cancer diagnoses increase each year, and current treatment strategies cause disturbing levels of serious side effects. This has necessitated a search for new strategies to employ more targeted treatments for malignant tissues. One promising alternative therapy is the use of a chemotherapeutic-nanoparticle-aptamer bioconjugate. This method employs aptamers which target over-expressed proteins on cancerous cell surfaces and bind to individual prostate tumour cells with incredible affinity. Once bound, the bioconjugate is taken into the cell where it delivers a toxic payload of chemotherapeutics and destroys the cell by cytotoxic means. The bioconjugate therapy method is specific for cancerous cells which limits side-effects to non-target tissues. Fluorescent properties of some chemotherapeutic components and quantum dot nanoparticles can also provide imaging of these cancerous masses with extreme precision. Successful trials employing aptamers for targeted therapy demonstrate the promise of this technology for future chemotherapeutic applications. Additionally, aptamer conjugates are safer, less expensive, and potentially more effective substitutes to antibody-based targeting methods which are currently being explored as a competing option for this type of treatment.Les diagnostics de cancer de la prostate augmentent chaque année, et les traitements actuelles qui leurs sont associés sont responsable d’un niveau inquiétant de graves effets secondaires. Cela a nécessité une recherche de nouvelles stratégies dans le traitement plus ciblés des tissus malins. Une thérapie alternative prometteuse se présente dans l'utilisation d'un agent chimiothérapeutique-nanoparticule-aptamer-bioconjugate. Ce procédé engage des aptamères qui ciblent les protéines surexprimées sur la surface des cellules cancéreuses et s’attachent à des individuels cellules tumorales de la prostate avec une affinité épatante. Une fois lié, le bioconjugué s’introduit dans la cellule où il livre une charge toxique de médicaments chimiothérapeutiques ce qui résulte dans la destruction cytotoxique de la cellule cancéreuse. Le procédé de thérapie bioconjugué se dirige vers des cellules cancéreuses ainsi épargnant des effets secondaires le tissu non ciblé. Des propriétés fluorescentes de certains composants chimiothérapeutiques et de nanoparticules de points quantiques aussi aident à fournir des images de ces masses cancéreuses avec une précision importante. Des essais concluants employant des aptamères comme thérapie ciblée distinguent comme prometteuse cette technologie dans des applications chimiothérapeutiques futures. De plus, des conjugués aptamères se sont montrés plus sûrs, moins coûteux, et potentiellement plus efficaces que leurs compétiteurs en traitement à base d'anticorps qui sont actuellement explorés comme option.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.092
Threshold uncertainty score0.212

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.360
Teacher spread0.337 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Student Science and TechnologySame topicAdvanced biosensing and bioanalysis techniquesFrench-language works237,207